Fig. 1

a. ‘A larger number of younger patients with T4 UICC stage II received adjuvant chemotherapy. b. The location of disease did not differ significantly between treated and untreated patients. c. Overall survival benefit for T4 UICC II colon cancer patients who received adjuvant chemotherapy (p < 0.001). d. All of the of adjuvant treatments used (5-Fluorouracil and folinic acid (FUFOL), FUFOL and oxaliplatin, Capecitabin and Oxaliplatin, and Capecitabine) appear to be beneficial compared to patients not receiving adjuvant chemotherapy. Patients over 80 years of age and those who died within 30 days after the diagnosis were excluded